MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results Cannabis Investing News
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib Biotech Investing
MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences Cannabis Investing News
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform Cannabis Investing News
BriaCell to Announce Early Efficacy Data of Lead Candidate in Combination with KEYTRUDA® at AACR Annual Meeting Biotech Investing
BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement Biotech Investing
Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa Pharmaceutical Investing
Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC Pharmaceutical Investing
